MARINUS PHARMACEUTICALS, INC. Repayments of Notes Payable
MARINUS PHARMACEUTICALS, INC. reported Repayments of Notes Payable of $5.25 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfNotesPayable · last filed 2019-03-12
- MARINUS PHARMACEUTICALS, INC. repayments of notes payable for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- MARINUS PHARMACEUTICALS, INC. repayments of notes payable for the quarter ending 2017-09-30 was $3.50M, a 249.35% increase year-over-year.
- MARINUS PHARMACEUTICALS, INC. repayments of notes payable for the quarter ending 2017-06-30 was $875.00K, a 588.98% increase year-over-year.
- MARINUS PHARMACEUTICALS, INC. repayments of notes payable for the quarter ending 2017-03-31 was $875.00K, a 967.07% increase year-over-year.
- MARINUS PHARMACEUTICALS, INC. repayments of notes payable for fiscal 2017 was $5.25M, a 146.57% increase from fiscal 2016.
- MARINUS PHARMACEUTICALS, INC. repayments of notes payable for fiscal 2016 was $2.13M, a 933.01% increase from fiscal 2015.
- MARINUS PHARMACEUTICALS, INC. repayments of notes payable for fiscal 2015 was $206.00K.
| Period end | Repayments of Notes Payable 3 month | Repayments of Notes Payable 6 month | Repayments of Notes Payable 9 month | Repayments of Notes Payable 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $3.50M derived: sum of 2 quarters · filed 2019-03-12 | $4.37M derived: sum of 3 quarters · filed 2019-03-12 | $5.25M 10-K · filed 2019-03-12 |
| 2017-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $4.37M derived: sum of 2 quarters · filed 2018-10-29 | $5.25M 10-Q · filed 2018-10-29 | $6.17M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | $875.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $1.75M 10-Q · filed 2018-08-03 | $2.67M derived: sum of 3 quarters · filed 2019-03-12 | $3.67M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $875.00K 10-Q · filed 2018-05-02 | $1.79M derived: sum of 2 quarters · filed 2019-03-12 | $2.79M derived: sum of 3 quarters · filed 2019-03-12 | $2.92M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $918.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $1.92M derived: sum of 2 quarters · filed 2019-03-12 | $2.05M derived: sum of 3 quarters · filed 2019-03-12 | $2.13M 10-K · filed 2019-03-12 |
| 2016-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $1.13M derived: sum of 2 quarters · filed 2017-10-31 | $1.21M 10-Q · filed 2017-10-31 | $1.33M derived: sum of 4 quarters · filed 2017-10-31 |
| 2016-06-30 | $127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $209.00K 10-Q · filed 2017-08-01 | $333.00K derived: sum of 3 quarters · filed 2017-08-01 | |
| 2016-03-31 | $82.00K 10-Q · filed 2017-05-01 | $206.00K derived: sum of 2 quarters · filed 2017-05-01 | ||
| 2015-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $206.00K 10-K · filed 2017-03-13 | ||
| 2015-09-30 | $82.00K 10-Q · filed 2015-10-29 |